Trial Profile

Cerebrovascular Reserve and White Matter Disease in Patients with Chronic Anemia

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 04 Nov 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Hydroxycarbamide (Primary)
Indications Sickle cell anaemia; Thalassaemia
Focus Pharmacodynamics
Acronyms CVR

Most Recent Events

03 May 2023 Status changed from recruiting to completed.
13 Jul 2022 Planned primary completion date changed from 1 Dec 2021 to 1 Dec 2022.
07 May 2021 Planned End Date changed from 1 Mar 2023 to 1 Dec 2022.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com